SIGLEC1 and viral infectious disease: Research has identified several leukocyte activation markers that hold promise for diagnosing and distinguishing bacterial and viral infections: particularly the expression of CD64 (FcgRI) on neutrophils (nCD64) and CD169 (Siglec-1) on classical monocytes (mCD169) (7, –, 11).